(Q38011596)
Statements
1 reference
Postmarketing surveillance study of erlotinib in Japanese patients with non-small-cell lung cancer (NSCLC): an interim analysis of 3488 patients (POLARSTAR). (English)
1 reference
Kazuhiko Nakagawa
1 reference
Shoji Kudoh
1 reference
Yuichiro Ohe
1 reference
Takeshi Johkoh
1 reference
Masahiko Ando
1 reference
Naoya Yamazaki
1 reference
Akihiro Seki
1 reference
Shinya Takemoto
1 reference
Masahiro Fukuoka
1 reference
1 August 2012
1 reference
1 reference
7
1 reference
8
1 reference
1296-1303
1 reference
Identifiers
1 reference
1 reference